SCHEMBL6965574

SCHEMBL6965574

CC(C)CC(SCc1ccccc1)c1c(O)cc(-c2ccc3c(c2)OCCO3)oc1=O

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
MAPT P10636 2/20 0.42
TERT O14746 1/20 0.40
KDM4E B2RXH2 4/20 0.39
HPGD P15428 3/20 0.39
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GSK3A P49840 1/20 0.37
GSK3B P49841 1/20 0.37
GAA P10253 1/20 0.37
CNR2 P34972 1/20 0.36
METAP2 P50579 1/20 0.36
HSP90AA1 P07900 1/20 0.35
USP2 O75604 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6954004 0.86 SMN1; SMN2 (0.41) ALDH1A1MAPTKDM4EHPGDTP53
SCHEMBL9056635 0.84 ALDH1A1 (0.38) ALDH1A1MAPTKDM4EHPGDRAB9A
SCHEMBL6964290 0.81 HTT (0.40) ALDH1A1MAPTKDM4EHPGDRAB9A
SCHEMBL7409285 0.77 ABCB1 (0.39) ALDH1A1MAPTKDM4EHPGDTP53
SCHEMBL6960313 0.77 TERT (0.52) ALDH1A1MAPTTERTKDM4EHPGD
SCHEMBL6953958 0.76 ABCB1 (0.38) MAPT
SCHEMBL6953451 0.73 SMN1; SMN2 (0.39) ALDH1A1MAPTKDM4EHPGDTP53
SCHEMBL6960131 0.73 ABCB1 (0.39) SMN1; SMN2
SCHEMBL6954754 0.72 SMN1; SMN2 (0.40) ALDH1A1MAPTKDM4EHPGDTP53
SCHEMBL6965576 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed